Evidence map›Paper›PMID 36114631›Full record

ArticlePalliative medicine2022

A think-aloud study of the feasibility of patients with end-stage organ failure completing the ICECAP-SCM.

Henry Nwankwo, Joanna Coast, Alistair Hewison, Philip Kinghorn, Shyam Madathil, Cara Bailey

Abstract read
In one paragraph

Article in Palliative medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Psychometric properties of the ICECAP-SCM capability-wellbeing measure in specialist palliative care units in Austria.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Henry NwankwoCentre for Health Economics at Warwick, Clinical Trials Unit, University of Warwick, Coventry, UK.ORCID 0000-0001-7401-1923
Joanna CoastHealth Economics Bristol, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Alistair HewisonSchool of Nursing, Institute of Clinical Sciences, University of Birmingham, Birmingham, UK.
Philip KinghornHealth Economics Unit, Institute of Applied Health Research, University of Birmingham, Birmingham, UK.ORCID 0000-0002-9333-1962
Shyam MadathilRespiratory Medicine Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Cara BaileySchool of Nursing, Institute of Clinical Sciences, University of Birmingham, Birmingham, UK.

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundThe ICECAP-Supportive Care Measure (SCM) is a self-complete measure developed to inform economic decision making at the end-of-life. Previous research has demonstrated its feasibility in hospice and nursing home settings. This is the first study of its use with patients on the organ failure trajectory.

aimTo determine the feasibility of using the ICECAP-SCM with patients experiencing end-stage organ failure in a hospital setting.

designParticipants were asked to 'think aloud' when completing the ICECAP-SCM, ICECAP-A and EQ-5D-5L measures. The interviews were transcribed verbatim and examined for errors in comprehension, retrieval, judgement, and response by five raters. Qualitative data were collected to explore reasons for errors in completing the measures and participants' views about the measures. SETTING/

participantsSixty patients (with end-stage renal failure

resultsParticipants reported that the measures were acceptable, clear, and easy to complete. Error rates in completing the measures were low (ICECAP-A = 3%,and ICECAP-SCM = 5.7% and EQ-5D-5L = 6.3%). There was some variation in responses between patients with different end-stage conditions, particularly those with symptom fluctuation. Some patients had not considered their end-of-life (i.e. advance care planning) and reported finding questions about this difficult to answer.

conclusionIt is feasible to use the ICECAP-SCM with patients with end-stage organ failure receiving care in hospital settings. This study provides evidence for researchers and policy makers involved in measuring end-of-life care globally. The ICECAP-SCM can be recommended for research with patients in end-stage organ failure to appropriately capture the broader benefits of end-of-life care.

Indexed as

Hospice CareQuality of LifeDeathHumansPatientsSurveys and QuestionnairesCOPDeconomic evaluationend-of-life careESRDheart failuremeasurementPalliative carequality of life

Identifiers

PMID36114631
PMCPMC9749016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.